These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17984168)

  • 1. Illuminating HDL--is it still a viable therapeutic target?
    Rader DJ
    N Engl J Med; 2007 Nov; 357(21):2180-3. PubMed ID: 17984168
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a blood pressure rise the only deleterious off-target effect of cholesterol ester transfer protein inhibitors?
    Miura S; Saku K
    J Hypertens; 2010 Aug; 28(8):1614-6. PubMed ID: 20647856
    [No Abstract]   [Full Text] [Related]  

  • 3. New drug fizzles at raising HDL. Tried-and-true strategies are still excellent ways to boost good cholesterol.
    Harv Heart Lett; 2007 Mar; 17(7):1-2. PubMed ID: 17378073
    [No Abstract]   [Full Text] [Related]  

  • 4. Torcetrapib: when global risk reduction goes 'off target'.
    Jackson G
    Int J Clin Pract; 2008 Feb; 62(2):173-4. PubMed ID: 18199271
    [No Abstract]   [Full Text] [Related]  

  • 5. HDL: back to the drawing board.
    Johns Hopkins Med Lett Health After 50; 2007 May; 19(3):1-2. PubMed ID: 17657883
    [No Abstract]   [Full Text] [Related]  

  • 6. Torcetrapib and coronary events.
    Dullaart RP; Kobold AC; van Tol A
    N Engl J Med; 2008 Apr; 358(17):1863; author reply 1863-4. PubMed ID: 18437725
    [No Abstract]   [Full Text] [Related]  

  • 7. The failure of torcetrapib: was it the molecule or the mechanism?
    Tall AR; Yvan-Charvet L; Wang N
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):257-60. PubMed ID: 17229967
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?
    Neeli H; Rader DJ
    Cardiol Clin; 2008 Nov; 26(4):537-46. PubMed ID: 18929230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is high HDL cholesterol always good?
    Olsson AG
    Ann Med; 2009; 41(1):11-8. PubMed ID: 19085339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torcetrapib and coronary events.
    Lackner KJ
    N Engl J Med; 2008 Apr; 358(17):1862-3; author reply 1863-4. PubMed ID: 18434657
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied.
    Masterjohn C
    Am Heart J; 2009 Jul; 158(1):e11; author reply e13. PubMed ID: 19540377
    [No Abstract]   [Full Text] [Related]  

  • 12. HDL: still a target for new therapies?
    Nicholls SJ
    Curr Opin Investig Drugs; 2008 Sep; 9(9):950-6. PubMed ID: 18729001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CETP inhibition.
    Duriez P
    Lancet; 2007 Dec; 370(9603):1882-3. PubMed ID: 18068495
    [No Abstract]   [Full Text] [Related]  

  • 14. Raising high-density lipoprotein: for better or worse?
    Tomlinson B
    Heart; 2010 Sep; 96(17):1339-40. PubMed ID: 20801851
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of torcetrapib, a lipid-lowering drug, abandoned.
    Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590910
    [No Abstract]   [Full Text] [Related]  

  • 16. [HDL and CETP in atherogenesis].
    Pöss J; Böhm M; Laufs U
    Dtsch Med Wochenschr; 2010 Feb; 135(5):188-92. PubMed ID: 20082258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL-cholesterol levels and cardiovascular risk: acCETPing the context.
    Lange RA; Lindsey ML
    Eur Heart J; 2008 Nov; 29(22):2708-9. PubMed ID: 18957471
    [No Abstract]   [Full Text] [Related]  

  • 18. Viability of developing CETP inhibitors.
    Sirtori CR; Mombelli G
    Cardiovasc Ther; 2008; 26(2):135-46. PubMed ID: 18485135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein inhibition: a dysfunctional endothelium.
    Westerterp M; Koetsveld J; Tall AR
    J Cardiovasc Pharmacol; 2010 May; 55(5):456-8. PubMed ID: 20351566
    [No Abstract]   [Full Text] [Related]  

  • 20. Torcetrapib and coronary events.
    Cohn LJ
    N Engl J Med; 2008 Apr; 358(17):1863; author reply 1863-4. PubMed ID: 18437724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.